spacer
home > pmps > winter 2019 > safe, secure, and simple
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Safe, Secure, and Simple

In this occasionally light-hearted account of the journey to gaining a certified child-resistant package under the 16 CFR 1700 regulations, it may be easy to forget the importance of doing this job properly. Children are wonderfully entertaining, frustratingly unpredictable, and unknowingly delicate creatures. They are also the future and represent the legacy of all hopes and dreams. This project was dedicated to protecting them as best as possible.

One of the things that makes any child-resistant test so difficult to pass is that kids, by their very nature, are inquisitive beings. It is amazing how interested they are in a simple cardboard box and just how much they want to open it to find out what is inside. Now imagine that the box is filled with something that looks like candy, but, in reality, the candy is filled with a potent psychoactive narcotic. An inquisitive child and controlled substances do not mix well, and a number of sobering facts can help maintain one’s focus when taking on a challenge like this.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dane Whitehurst is the Creative Director at Burgopak and Duallok. He has worked with a wide range of international clients over his career in packaging design and has spoken internationally on the subject. Dane is a visiting lecturer at Ravensbourne College and the Royal College of Art in London, UK, and has a host of patents and international design awards to his name. He graduated from Central Saint Martins, UK, in 2005 with a master’s degree in industrial design.
spacer
Dane Whitehurst
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Protagen Protein Services (PPS) reaches new level in characterizing HCP protein impurities

In response to current regulatory guidance a Mass Spectrometry (MS) based Host Cell Protein (HCP) detection approach with faster, more accurate and wider-ranging detection is essential. In order to meet the newly prevailing demands Protagen Protein Services (PPS) recently invested in more far-reaching MS capabilities: The new high-performing mass spectrometer ThermoFisher Q Exactive™ HF-X started operational service last month and brings PPS to the next level of reproducible, accurate and sensitive analyses of majorly complex samples for different aspects of translational research and biopharma applications.
More info >>

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

 
Industry Events

Respiratory Drug Delivery (RDD®) Europe 2019

7-10 May 2019, Estoril Congress Center, Lisbon

Respiratory Drug Delivery (RDD®) Europe 2019 connects emerging and high-level scientists, academics, industrial and regulatory specialists, and clinicians. It is a must-attend conference for companies involved in research, development, testing or marketing of medicines, devices and services associated with pulmonary or nasal pharmaceutical products. This year, RDD Europe 2019 will be held in Estoril (Lisbon), Portugal, May 7-10, 2019, and, as in previous years is jointly organized by RDD Online and Aptar Pharma.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement